fluorodeoxyglucose f18 has been researched along with Lung Diseases, Interstitial in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (10.34) | 29.6817 |
2010's | 11 (37.93) | 24.3611 |
2020's | 15 (51.72) | 2.80 |
Authors | Studies |
---|---|
Chen, D; Liang, J; Lin, J; Liu, Y; Su, X; Wang, G; Wang, H; Yan, J; Zhao, K; Zhao, X | 1 |
Bastos, AL; Correa, RA; Ferreira, CS; Ferreira, GA; Mamede, M; Mancuzo, EV; Santos, FPST; Teixeira, MM | 1 |
Buchpigel, CA; Kairalla, RA; Sawamura, MVY | 1 |
Kagimoto, A; Kambara, T; Kushitani, K; Mimae, T; Miyata, Y; Okada, M; Takeshima, Y; Tsutani, Y | 1 |
Knol, RJJ; van der Zant, FM | 1 |
Date, H | 1 |
Hoekstra, OS; Meijboom, LJ; Nossent, EJ; Peelen, DM; Van der Laken, CJ; Voskuyl, AE; Zwezerijnen, BGJC | 1 |
Albano, D; Bertagna, F; Camoni, L; Giubbini, R; Rinaldi, R | 1 |
Handa, Y; Kagimoto, A; Mimae, T; Miyata, Y; Okada, M; Tsutani, Y | 1 |
Albano, D; Alongi, P; Baldari, S; Baldoncini, A; Balducci, MT; Bartolomei, M; Bertagna, F; Boccaletto, F; Boero, M; Borsatti, E; Bruno, A; Burroni, L; Calcagni, ML; Capoccetti, F; Castellani, M; Cervino, AR; Chierichetti, F; Ciarmiello, A; Corso, A; Cuocolo, A; De Rimini, ML; Deandreis, D; Dottorini, ME; Esposito, F; Evangelista, L; Farsad, M; Garufo, A; Gasparini, M; Giubbini, R; Grana, CM; Gregianin, M; Guerra, L; Loreti, F; Lupi, A; Maroldi, R; Martino, G; Marzola, MC; Milan, E; Modoni, S; Morbelli, S; Muni, A; Nicolai, E; Palumbo, B; Papa, S; Papaleo, A; Pellerito, R; Poti, C; Romano, P; Rossetti, C; Rossini, P; Rubini, G; Ruffini, L; Sacchetti, G; Savelli, G; Schiavariello, S; Schillaci, O; Sciagrà, R; Sciuto, R; Seregni, E; Sestini, S; Sicolo, M; Spanu, A; Storto, G; Trifirò, G; Versari, A; Vignati, A; Volterrani, D | 1 |
Aaløkken, TM; Aukrust, P; Durheim, MT; Fevang, B; Fraz, MSA; Jørgensen, SF; Macpherson, ME; Moe, N; Nordøy, I; Revheim, ME; Stavrinou, ML | 1 |
Baillet, C; Béhal, H; Hachulla, E; Huglo, D; Launay, D; Le Gouellec, N; Ledoult, E; Mékinian, A; Morelle, M; Remy-Jardin, M; Sobanski, V; Soussan, M | 1 |
Cao, H; He, Y; Ke, Y; Liang, J; Lin, J; Liu, Y; Sun, Y; Xu, B; Ye, B | 1 |
Bruna-Muraille, C; Dejust, S; Eymard, JC; Morland, D; Papathanassiou, D; Savoye, AM; Yazbek, G | 1 |
Allanore, Y; Avouac, J; Bellando-Randone, S; Blagojevic, J; Bruni, C; Cavigli, E; De Cristofaro, MT; Distler, O; Guiducci, S; Lepri, G; Matucci-Cerinic, M; Mihai, C; Moggi-Pignone, A; Passeri, A; Tartarelli, L; Tofani, L | 1 |
Fujiwara, C; Hara, K; Higuchi, T; Hirasawa, H; Ishikawa, O; Kodaira, S; Maeno, T; Motegi, SI; Sekiguchi, A; Tomonaga, H; Tsushima, Y; Yamaguchi, K | 1 |
Handra-Luca, A | 1 |
Cipriani, C; De Cosmo, S; Dimitri, LMC; Frongillo, E; Simeone, A; Sperandeo, M; Taurchini, M | 1 |
Endo, M; Isaka, M; Kondo, H; Maniwa, T; Nakagawa, K; Ohde, Y; Okumura, T | 1 |
Hama, M; Ihata, A; Ishigatsubo, Y; Suda, A; Takeno, M; Tateishi, U; Ueda, A; Uehara, T; Yoshimi, R | 1 |
Brandi, L; Carbonelli, C; Cavazza, A; Cesario, A; Di Paolo, ML; Gasparini, E; Lococo, F; Paci, M; Rapicetta, C; Ricchetti, T; Serra, S; Sgarbi, G; Sverzellati, N | 1 |
Brillet, PY; Fain, O; Jacquelin, V; Mekinian, A; Nunes, H; Soussan, M; Valeyre, D | 1 |
Brouns, M; Carne, E; El-Shanawany, T; Fielding, P; Jolles, S; Marshall, C; Williams, P | 1 |
Berovic, M; Booth, H; Dickson, JC; Ell, PJ; Endozo, R; Groves, AM; Kayani, I; Menezes, LJ; Screaton, NJ; Win, T | 1 |
Fukuda, H; Goto, R; Inoue, K; Kinomura, S; Okada, K; Taki, Y | 1 |
Hata, Y; Homma, S; Isobe, K; Shibuya, K; Sugino, K; Takai, Y | 1 |
Curiel, R; Hashefi, M | 1 |
Dickson, J; Ell, PJ; Endozo, R; Groves, AM; Kayani, I; Porter, J; Reubi, JC; Screaton, NJ; Shortman, RI; Wild, D; Win, T | 1 |
Isono, M; Kato, N; Kuwagata, S; Mizutani, H; Morita, Y; Suehiro, M; Tsujimura, Y | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Lung Diseases, Interstitial
Article | Year |
---|---|
Future and upcoming non-neoplastic applications of PET/CT imaging.
Topics: Fibromyalgia; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Osteoarthritis; Positron-Emission Tomography; Thrombosis | 2011 |
1 trial(s) available for fluorodeoxyglucose f18 and Lung Diseases, Interstitial
Article | Year |
---|---|
Novel positron emission tomography/computed tomography of diffuse parenchymal lung disease combining a labeled somatostatin receptor analogue and 2-deoxy-2[18F]fluoro-D-glucose.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Idiopathic Interstitial Pneumonias; Idiopathic Pulmonary Fibrosis; Lung Diseases, Interstitial; Male; Multimodal Imaging; Positron-Emission Tomography; Receptors, Somatostatin; Staining and Labeling; Tomography, X-Ray Computed | 2012 |
27 other study(ies) available for fluorodeoxyglucose f18 and Lung Diseases, Interstitial
Article | Year |
---|---|
Elevated spleen FDG uptake predicts unfavorable outcome in adult idiopathic-inflammatory-myopathy patients: a crisis beyond muscles.
Topics: Adult; Autoimmune Diseases; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Muscles; Myositis; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Spleen | 2022 |
PET/CT and inflammatory mediators in systemic sclerosis-associated interstitial lung disease.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Fluorodeoxyglucose F18; Humans; Inflammation Mediators; Ligands; Lung; Lung Diseases, Interstitial; Positron Emission Tomography Computed Tomography; Scleroderma, Systemic | 2022 |
PET/CT and interstitial lung disease.
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases, Interstitial; Positron Emission Tomography Computed Tomography | 2022 |
Usefulness of serum S100A4 and positron-emission tomography on lung cancer accompanied by interstitial pneumonia.
Topics: Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Positron-Emission Tomography; Retrospective Studies; S100 Calcium-Binding Protein A4 | 2023 |
FDG-Avid Granulomatous Lymphocytic Interstitial Lung Disease With Common Variable Immunodeficiency.
Topics: Adult; Common Variable Immunodeficiency; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Commentary: How to predict disaster?
Topics: Disasters; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Lung Neoplasms | 2020 |
The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients.
Topics: Adult; Aged; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Scleroderma, Systemic; Sjogren's Syndrome | 2020 |
18F-FDG PET/CT Metabolic Behavior of COVID-19 Pneumonia: A Series of 4 Patients With RT-PCR Confirmation.
Topics: Aged; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Pandemics; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2 | 2020 |
Prediction of Acute Exacerbation of Interstitial Pneumonia Using Visual Evaluation of PET.
Topics: Adult; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Positron Emission Tomography Computed Tomography; Postoperative Complications; Preoperative Care; Prognosis; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2021 |
Prevalence of interstitial pneumonia suggestive of COVID-19 at
Topics: COVID-19; Fluorodeoxyglucose F18; Humans; Italy; Lung Diseases, Interstitial; Pandemics; Positron Emission Tomography Computed Tomography; Prevalence; Retrospective Studies; SARS-CoV-2 | 2021 |
Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and
Topics: Common Variable Immunodeficiency; Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Positron Emission Tomography Computed Tomography; Respiratory Function Tests; Respiratory Insufficiency; Retrospective Studies | 2020 |
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases, Interstitial; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Scleroderma, Systemic | 2021 |
The lungs were on fire: a pilot study of
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases, Interstitial; Myositis; Pilot Projects; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Everolimus-induced pulmonary toxicity: Findings on 18F-FDG PET/CT imaging.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Breast Neoplasms; Everolimus; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Diseases, Interstitial; Middle Aged; Positron Emission Tomography Computed Tomography; TOR Serine-Threonine Kinases; Tumor Burden | 2018 |
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Scleroderma, Systemic | 2019 |
Clinical value of
Topics: Adult; Aged; Dermatomyositis; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases, Interstitial; Magnetic Resonance Imaging; Male; Middle Aged; Mucin-1; Muscle, Skeletal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2019 |
Xanthomatous Interstitial Pneumopathy: Chemotherapy- or Contrast Substance Related Change?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Iopamidol; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Xanthomatosis | 2020 |
Video-assisted thoracic surgery ultrasound (VATS-US) in the evaluation of subpleural disease: preliminary report of a systematic study.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Ultrasonography | 2020 |
Acute exacerbation of interstitial lung disease with lung cancer after surgery: evaluation with 2-[18]-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Acute Disease; Aged; Aged, 80 and over; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2014 |
Deep-inspiration breath-hold 18F-FDG-PET/CT is useful for assessment of connective tissue disease associated interstitial pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Breath Holding; Connective Tissue Diseases; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
A 79-Year-Old Man With Interstitial Lung Disease and Cryptic Area of High 18 Fluorodeoxyglucose Uptake in Left Upper Lobe.
Topics: Adenocarcinoma; Aged; Carcinoembryonic Antigen; Colectomy; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Monitoring, Physiologic; Neoplasms, Second Primary; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
FDG-PET/CT in the prediction of pulmonary function improvement in nonspecific interstitial pneumonia. A Pilot Study.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Forced Expiratory Volume; Forecasting; Humans; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Pulmonary Fibrosis; Radiographic Image Enhancement; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Total Lung Capacity; Treatment Outcome; Vital Capacity | 2016 |
FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).
Topics: Adult; Common Variable Immunodeficiency; Female; Fluorodeoxyglucose F18; Granuloma, Respiratory Tract; Humans; Lung; Lung Diseases, Interstitial; Lymphocytes; Middle Aged; Mycophenolic Acid; Positron-Emission Tomography; Rituximab; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Male; Pilot Projects; Positron-Emission Tomography; Pulmonary Fibrosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique | 2009 |
(18)FDG uptake associated with CT density on PET/CT in lungs with and without chronic interstitial lung diseases.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
[Usefulness of FDG-PET for diagnosis of lung cancer associated with interstitial pneumonia].
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2009 |
18F-FDG PET/CT useful for the early detection of rapidly progressive fatal interstitial lung disease in dermatomyositis.
Topics: Aged; Dermatomyositis; Disease Progression; Early Diagnosis; Fatal Outcome; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |